These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 16989074

  • 1. Effects of calcium channel blockers on experimental glomerular injury.
    Dworkin LD.
    J Am Soc Nephrol; 1990 Sep; 1(3 Suppl 1):S21-7. PubMed ID: 16989074
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
    Bauer JH, Reams GP.
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Renal vascular effects of calcium channel blockers in hypertension.
    Benstein JA, Dworkin LD.
    Am J Hypertens; 1990 Dec; 3(12 Pt 2):305S-312S. PubMed ID: 2078317
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Glomerular hemodynamics in progressive renal disease.
    Ofstad J, Horvei G, Kvam FI, Mørkrid L, Sekse I, Svarstad E, Iversen BM.
    Kidney Int Suppl; 1992 May; 36():S8-14. PubMed ID: 1614073
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Class differences in the effects of calcium channel blockers in the rat remnant kidney model.
    Griffin KA, Picken MM, Bakris GL, Bidani AK.
    Kidney Int; 1999 May; 55(5):1849-60. PubMed ID: 10231447
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Calcium antagonists and the kidney.
    Epstein M.
    J Cardiovasc Pharmacol; 1994 May; 24 Suppl A():S18-24. PubMed ID: 7603073
    [Abstract] [Full Text] [Related]

  • 12. Effect of renal disease on glomerular proteinases.
    Teschner M, Schaefer RM, Paczek L, Heidland A.
    Miner Electrolyte Metab; 1992 May; 18(2-5):92-6. PubMed ID: 1465087
    [Abstract] [Full Text] [Related]

  • 13. [Mechanisms of progression of glomerular sclerosis in chronic renal diseases in man].
    Garini G, Allegri L, Arisi L.
    Ann Ital Med Int; 1989 May; 4(3):184-94. PubMed ID: 2702030
    [Abstract] [Full Text] [Related]

  • 14. Effects of calcium antagonists on renal hemodynamics.
    Epstein M, Loutzenhiser RD.
    Am J Kidney Dis; 1990 Oct; 16(4 Suppl 1):10-4. PubMed ID: 2220795
    [Abstract] [Full Text] [Related]

  • 15. Reversal of proteinuric renal disease and the emerging role of endothelin.
    Barton M.
    Nat Clin Pract Nephrol; 2008 Sep; 4(9):490-501. PubMed ID: 18648345
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hypertensive nephrosclerosis.
    Hill GS.
    Curr Opin Nephrol Hypertens; 2008 May; 17(3):266-70. PubMed ID: 18408477
    [Abstract] [Full Text] [Related]

  • 20. [Effect of badoushuang on progressive glomerular sclerosis in rats with 7/8 nephrectomy].
    Zheng LZ, Makino H, Ota Z, Yoshifusa H.
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):743-51. PubMed ID: 1770634
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.